A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration
NCT01929460 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2016-02-15
Summary
Our hypothesis is that a single dose of antibiotics at time of EUS-guided pancreatic cyst aspiration is equally effective to the usual regimen of 3 days of post-procedural antibiotics.
Conditions
- Pancreatic Cysts
Interventions
- DRUG
-
ciprofloxacin oral capsule (one capsule twice a day for 3 days)
- OTHER
-
Placebo (for ciprofloxacin)
oral placebo capsule (one capsule twice a day for 3 days)
Sponsors & Collaborators
-
Kaiser Permanente
lead OTHER
Principal Investigators
-
Karl Kwok, MD · Principal Investigator
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance
NCT02955888 ·Status: TERMINATED ·Phase: PHASE2
-
Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa
NCT00638365 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa
NCT01090908 ·Status: WITHDRAWN
-
Registry and Fluid Banking of Pancreatic Cystic Lesions
NCT01769534 ·Status: TERMINATED
-
Open-Label Phase III Long-Term Safety Trial of Liprotamase
NCT00449904 ·Status: COMPLETED ·Phase: PHASE3
-
Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
NCT00510484 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
NCT03000348 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis
NCT00645788 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)
NCT00408317 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
NCT04279769 ·Status: COMPLETED ·Phase: PHASE1
-
First Study of Oral Cysteamine in Cystic Fibrosis
NCT02212431 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections
NCT07280598 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor
NCT02015507 ·Status: COMPLETED ·Phase: PHASE1
-
Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis
NCT01223183 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
NCT00763412 ·Status: COMPLETED ·Phase: NA
-
A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
NCT02137382 ·Status: COMPLETED ·Phase: PHASE3
-
Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
NCT02718495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients
NCT02421120 ·Status: COMPLETED ·Phase: PHASE4
-
LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients
NCT02840136 ·Status: TERMINATED ·Phase: NA
-
Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
NCT01879228 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis
NCT05225805 ·Status: COMPLETED ·Phase: PHASE1
-
SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis
NCT02279498 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
NCT00097773 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis
NCT04335370 ·Status: COMPLETED
-
CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)
NCT04684641 ·Status: COMPLETED ·Phase: PHASE1/PHASE2